Surgical therapy for Parkinson's disease

Area of Science:

• Neurology
• Neurosurgery
• Movement Disorders

Background:

• Conventional dopaminergic therapies for Parkinson's disease (PD) have limitations.
• Advancements in surgical techniques and understanding of basal ganglia function are driving new therapeutic approaches.
• Deep brain stimulation (DBS) is increasingly favored over ablative procedures.

Purpose of the Study:

• To review the current landscape of surgical therapies for Parkinson's disease.
• To compare the efficacy and limitations of different surgical interventions.
• To highlight emerging therapeutic strategies.

Main Methods:

• Review of existing studies on surgical interventions for Parkinson's disease.
• Comparison of deep brain stimulation (targeting subthalamic nucleus or globus pallidus pars interna) with ablative procedures and pharmacotherapy.
• Discussion of experimental approaches like fetal transplantation, stem cell, trophic factor, and gene therapy.

Main Results:

• Deep brain stimulation (DBS) of the subthalamic nucleus or globus pallidus pars interna offers benefits for advanced PD patients without destructive lesions.
• DBS provides motor benefits comparable to levodopa but with reduced motor complications.
• Fetal transplantation has shown limited efficacy and is associated with dyskinesia.

Conclusions:

• Deep brain stimulation is a valuable surgical option for advanced Parkinson's disease, offering symptom relief and improved motor control.
• While promising, experimental therapies such as stem cell, trophic factor, and gene therapy require further intensive investigation.
• Surgical interventions are evolving, providing alternatives and adjuncts to dopaminergic therapy for Parkinson's disease management.